Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA LUPIN ELDER PHARMA/
LUPIN
 
P/E (TTM) x -1.0 40.6 - View Chart
P/BV x 0.1 6.0 1.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 ELDER PHARMA   LUPIN
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
LUPIN
Mar-23
ELDER PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs380799 47.6%   
Low Rs188583 32.2%   
Sales per share (Unadj.) Rs489.2365.8 133.7%  
Earnings per share (Unadj.) Rs-3.29.8 -32.3%  
Cash flow per share (Unadj.) Rs14.429.2 49.4%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs376.5270.7 139.1%  
Shares outstanding (eoy) m20.54454.98 4.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.61.9 30.7%   
Avg P/E ratio x-89.370.2 -127.2%  
P/CF ratio (eoy) x19.723.7 83.3%  
Price / Book Value ratio x0.82.6 29.5%  
Dividend payout %040.7 -0.0%   
Avg Mkt Cap Rs m5,832314,381 1.9%   
No. of employees `000NANA-   
Total wages/salary Rs m2,17930,872 7.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,048166,417 6.0%  
Other income Rs m2571,509 17.0%   
Total revenues Rs m10,305167,926 6.1%   
Gross profit Rs m2,92117,206 17.0%  
Depreciation Rs m3618,807 4.1%   
Interest Rs m2,7562,743 100.5%   
Profit before tax Rs m607,165 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1252,688 4.7%   
Profit after tax Rs m-654,477 -1.5%  
Gross profit margin %29.110.3 281.2%  
Effective tax rate %209.137.5 557.4%   
Net profit margin %-0.62.7 -24.2%  
BALANCE SHEET DATA
Current assets Rs m9,240124,513 7.4%   
Current liabilities Rs m9,99892,654 10.8%   
Net working cap to sales %-7.519.1 -39.4%  
Current ratio x0.91.3 68.8%  
Inventory Days Days12826 489.2%  
Debtors Days Days60298 612.4%  
Net fixed assets Rs m13,642103,490 13.2%   
Share capital Rs m206910 22.6%   
"Free" reserves Rs m7,528122,246 6.2%   
Net worth Rs m7,733123,156 6.3%   
Long term debt Rs m4,889275 1,777.2%   
Total assets Rs m22,882228,003 10.0%  
Interest coverage x1.03.6 28.3%   
Debt to equity ratio x0.60 28,301.3%  
Sales to assets ratio x0.40.7 60.2%   
Return on assets %11.83.2 371.4%  
Return on equity %-0.83.6 -23.2%  
Return on capital %22.38.0 277.9%  
Exports to sales %3.10-   
Imports to sales %0.40-   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m43NA-   
Fx inflow Rs m30748,057 0.6%   
Fx outflow Rs m12521,752 0.6%   
Net fx Rs m18126,306 0.7%   
CASH FLOW
From Operations Rs m11,75418,972 62.0%  
From Investments Rs m-561-12,868 4.4%  
From Financial Activity Rs m-6,762-3,373 200.5%  
Net Cashflow Rs m5,4662,732 200.1%  

Share Holding

Indian Promoters % 25.3 46.8 54.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 24.0 45.8 52.3%  
FIIs % 0.0 16.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 53.0 141.0%  
Shareholders   31,548 281,542 11.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Elder Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Lupin Share Price Performance

Period Elder Pharma Lupin S&P BSE HEALTHCARE
1-Day 4.97% -1.60% 0.88%
1-Month 21.21% 1.63% -4.09%
1-Year -64.54% 149.67% 59.00%
3-Year CAGR -51.65% 17.29% 18.97%
5-Year CAGR -37.46% 16.42% 19.20%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.